How Much Of Your Portfolio Is Really CVS?

You didn’t buy this single stock, but after a powerful run, your favorite ETF might have made a big bet on it for you.

After returning +73% over the past year, shares of healthcare provider CVS Health (CVS) have quietly become a larger piece of many investors’ portfolios. The thing is, you may not have chosen to own it at all. It is held across 45 different equity funds, meaning if you own a broad health care or value ETF, you likely own a concentrated position in a stock that has climbed sharply, especially with its +43% return in just the last three months.

How Stretched Has The Stock Become?

A stock’s price can run well ahead of its own long-term trend, creating a gap that can close quickly. Right now, CVS Health trades about 30% above its 200-day moving average, a simple measure of its recent momentum. The stock is priced at about 14 times its expected earnings for the year ahead, with profits forecast to grow about 14% a year. This kind of run-up naturally leads to questions about what is already priced into the stock.

Which Of Your Funds Are Riding It Hardest?

The exposure is not spread evenly. The most concentrated holding is in the iShares U.S. Healthcare Providers ETF (IHF), which holds CVS at about 14.5% of the fund. That heavyweight helped power its +29% return over the past year. Other broad funds carry it, but in much smaller sizes. The State Street Health Care Select Sector SPDR ETF (XLV) holds CVS at about 2.2% of the fund, while the Vanguard Health Care ETF (VHT) holds it at about 1.8%. Those funds also posted strong returns, but with far less reliance on this single name.

What A Pullback Would Actually Cost

This is not a prediction, but a scenario to make the risk concrete. If CVS simply fell back to its 200-day average, the stock would drop about 23% from its current price. For the funds holding it, the impact is simple math. The iShares U.S. Healthcare Providers ETF (IHF) would lose about 3.3% of its value from this one holding alone. For the more diversified funds, the hit would be smaller: the State Street Health Care Select Sector SPDR ETF (XLV) would lose about 0.5%, and the Vanguard Health Care ETF (VHT) would lose about 0.4%. The problem is that this exposure is sticky. You cannot surgically sell just the CVS shares inside your ETF; you would have to sell the entire fund, potentially creating a taxable capital gain.

A Way To Keep The Theme With Less Concentration

If you want to maintain exposure to the sector but dial back the single-stock risk, there are other options. The iShares MSCI USA Value Factor ETF (VLUE), for example, holds CVS at about 1.5% of the fund. That is a fraction of the nearly 15% weight in IHF. It is a very different construction, and it has performed well, returning +70% over the past year. The point is not that one fund is better, but that you have choices about how much concentration you are willing to accept.

The goal here is awareness. A stock that has performed this well can feel like a permanent winner, but its weight in your portfolio may have grown beyond what you intended. Knowing your true exposure is the first step to managing it.

How Do You Find A Better-Balanced Fund?

Whether this is a name you are happy to keep riding, or one you would rather not own quite so much of, the first move is the same: see your true exposure to it, then find funds that carry the same theme with less of any single stock. A fund’s name tells you almost nothing about how concentrated it has quietly become.

Our ETF Valuation and Performance Scorecard ranks the major ETFs side by side on valuation, return, and risk, so you can see which funds lean hardest on a handful of names and which spread the exposure while keeping the performance.

Is There A Cleaner Way To Invest?

And if the whole problem, a winner quietly growing into an outsized, hard-to-trim position you never sized on purpose, is something you would rather avoid by design, there is another way to think about it. An index fund holds whatever its benchmark dictates and never trims a winner for you, so concentration builds silently until a pullback does the trimming.

Our High Quality (HQ) Portfolio takes the opposite approach: rule-based, multi-factor selection across different kinds of businesses, rebalanced on a schedule, so winners get trimmed and no single name quietly becomes the whole position. It has a record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000.